Updated Date: Thu, 02 Feb 2023 00:00:00 EST

Updated Date: Thu, 02 Feb 2023 00:00:00 EST

Updated Date: Thu, 02 Feb 2023 00:00:00 EST

Positive results showed the TSST-1 vaccine is effective with immunisation lasting for at least two years

The companies anticipate that the EMA could also recommend marketing authorisation for AVT04

The pathway is a programme designed to develop pharmacists’ knowledge of mental health among patients

The treatment has been developed to treat certain chronic heart failure patients and is approved elsewhere

Updated Date: Tue, 31 Jan 2023 00:00:00 EST

Financing will allow company’s development of DNA synthesis chip technology to commercial scale

Milestone therapy concerns the treatment of patients with symptomatic chronic heart failure